Compare · DFTX vs MEHA
DFTX vs MEHA
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Functional Brands Inc. (MEHA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and MEHA operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $6.02B, about 7492.8x MEHA ($803,570).
- DFTX has been more active in the news (15 items in the past 4 weeks vs 2 for MEHA).
- DFTX has more recent analyst coverage (7 ratings vs 0 for MEHA).
- Company
- Definium Therapeutics Inc.
- Functional Brands Inc.
- Price
- $44.77+3.55%
- $0.02-53.98%
- Market cap
- $6.02B
- $803,570
- 1M return
- -
- +0.00%
- 1Y return
- -
- -99.30%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 15
- 2
- Recent ratings
- 7
- 0
Latest DFTX
- BofA Securities initiated coverage on Definium Therapeutics with a new price target
- Definium Therapeutics Announces New Employee Inducement Grants
- Amendment: SEC Form SCHEDULE 13G/A filed by Definium Therapeutics Inc.
- Chief Commercial Officer Wiley Matthew T. was granted 62,500 shares, increasing direct ownership by 36% to 237,133 units (SEC Form 4)
- Chief Medical Officer Karlin Daniel was granted 100,000 shares, increasing direct ownership by 20% to 603,282 units (SEC Form 4)
- Chief Financial Officer Roberts Brandi was granted 62,500 shares, increasing direct ownership by 30% to 271,987 units (SEC Form 4)
- Chief Executive Officer Barrow Robert was granted 375,000 shares, increasing direct ownership by 34% to 1,473,246 units (SEC Form 4)
- Chief Legal Officer Sullivan Mark was granted 62,500 shares, increasing direct ownership by 19% to 383,071 units (SEC Form 4)
- Definium Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder
Latest MEHA
- Functional Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Functional Brands Announces Second Quarter 2026 Financial Results
- SEC Form 25-NSE filed by Functional Brands Inc.
- Functional Brands Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits
- Functional Brands Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement
- Functional Brands Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
- Functional Brands Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- SEC Form DEFA14A filed by Functional Brands Inc.
- SEC Form DEFA14A filed by Functional Brands Inc.
- Amendment: Functional Brands Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits